New gel injections aim to smooth cheek wrinkles

NCT ID NCT07344584

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 2 times

Summary

This pilot study will test the safety and effectiveness of two injectable gels, GP0122 and GP0124, for reducing lines and wrinkles in the cheek area. About 60 adults with moderate to severe cheek wrinkles will receive the treatment and be followed for 12 months. The main goal is to check for side effects and pain, with secondary goals looking at wrinkle improvement.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

Injectable gel (GP0122 and GP0124)

What this could lead to

If successful, this could lead to a new, safe option for reducing cheek wrinkles.

What could go wrong

This is a small, early pilot study with only 60 participants. It focuses on safety first, so effectiveness is not yet proven. Results may not apply to everyone.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for WRINKLE REDUCTION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••